Legal News

Title II of the DQSA is the Drug Supply Chain Security Act. As of January 1, 2015, new changes and mandates will move all members of the supply chain closer to becoming mandatory oversight partners with FDA.

The California State Supreme Court recently upheld a ruling that allows healthcare plans serving the poor to ignore what it costs pharmacies to obtain drugs when establishing Medi-Cal reimbursement rates.

A pharmacist must have a valid license issued by the board of the state in which he wishes to practice. New pharmacy graduates need to investigate individual state pharmacy board requirements.

A former West El Paso, Texas pharmacist will represent himself in a retrial on charges he fraudulently billed insurers for prescriptions never dispensed and sold drugs to an undercover federal agent, according to a published report.

A federal judge has blocked Massachusetts’ attempt to ban the controversial new painkiller Zohydro ER, which law enforcement officials, politicians, and some healthcare officials fear will dramatically increase opioid overdose deaths.

CVS Caremark Corp. faces as much as $29 million in fines associated with 37,000 prescription painkillers that are missing from four of its California stores, according to a report in the Los Angeles Times.

After pleading guilty to unlawful importation of drugs, a San Diego pharmacist has been ordered to repay Medicare $1 million.William Burdine, 65, owner of the Alvarado Medical Plaza Pharmacy in San Diego, was also sentenced to eight months of home confinement, 240 hours of community service, five years of probation, and a $10,000 fine.

CMS is proposing a modified interpretation of the existing non-interference provisions that would remove any limitation on CMS’ regulation of the relationship between pharmacies and plan sponsors.

A Christian pharmacist in Tennessee has filed a federal lawsuit against Walgreens claiming the chain fired him for refusing to sell the Plan B morning after pill.

Boehringer Ingelheim is facing lawsuits in the United States over claims that Pradaxa, a blood-thinner used to reduce the risk of stroke and blood clots in people with atrial fibrillation, causes severe and fatal bleeding.

Drug Topics provides special coverage on pharmacy crimes involving the painkiller oxycodone. Discover what has happened recently in the news and current statistics of oxycodone trafficking offenses.

Since the NECC-triggered outbreak of fungal meningitis in 2012, FDA has responded aggressively, inspected almost 70 pharmacies. Now it is supported by a new law, the DQSA, and many new questions arise.